Drugs / SSP-004184SS
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01989169 | Nov 2013 → Jan 2014 | — | Shire | Completed | No outcome recorded |
| Phase 1 | NCT01979185 | Nov → Dec 2013 | — | Shire | Completed | No outcome recorded |
| Phase 1 | NCT01905553 | Aug → Sep 2013 | — | Shire | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SSP-004184SS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01905553 ↗ |
| Route | Oral | “21.8 mg/kg (oral capsule form)” NCT01905553 ↗ |